Empower Advisory Group LLC lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 5.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,744 shares of the financial services provider’s stock after selling 94 shares during the period. Empower […]
Column Capital Advisors LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 401 shares of the financial services provider’s stock, valued at approximately $49,000. Several other institutional investors have also added to or reduced their stakes in the company. Leo […]
Pacific Capital Wealth Advisors Inc. lessened its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 8.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 63,695 shares of the financial services provider’s stock after selling 6,121 shares during the […]
Pacific Capital Wealth Advisors Inc. reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 8.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,695 shares of the financial services provider’s stock after selling 6,121 […]
Blume Capital Management Inc. lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.6% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 53,551 shares of the financial services provider’s stock after selling 867 shares during the period. iShares Biotechnology ETF […]